(Hypertension. 2000;35:1019.)
© 2000 American Heart Association, Inc.
Editorial |
1 Editor-in-Chief
| Introduction |
|---|
In response to this unacceptable situation, Dr Claude Lenfant, director of the National Heart, Lung, and Blood Institute of the National Institutes of Health, which is the sponsor of the NHBPEP, provoked intensified discussion on this subject. He advocated increased attention to this problem while not dispiriting the public. Consequently, in this issue of Hypertension, we are pleased to feature a report from the NHBPEP on a renewed need to identify patients with elevated systolic arterial pressures, to evaluate their medical circumstances, and then to bring their systolic arterial pressure under control with the use of lifestyle interventions, if possible, and/or with pharmacological interventions if not.
There are several possible reasons why the problem of
systolic pressure elevation has not achieved the attention that
it deserves. First, it was not until recent years that systolic
blood pressure was found to be of major importance.3 4 5 6
However, treatment of patients with systolic hypertension has
been advocated since publication of JNC-4.7
This article has been cited by other articles:
![]() |
A.G. Logan, R. Tkacova, S.M. Perlikowski, R.S. Leung, A. Tisler, J.S. Floras, and T.D. Bradley Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex Eur. Respir. J., February 1, 2003; 21(2): 241 - 247. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |